Bioplasma (Hyland’s)


Welcome to the PulseAid listing for the Bioplasma drug offered from Hyland’s. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Hyland’s
NON-PROPRIETARY NAME: CALCIUM FLUORIDE, TRIBASIC CALCIUM PHOSPHATE, CALCIUM SULFATE ANHYDROUS, FERROSOFERRIC PHOSPHATE, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, POTASSIUM SULFATE, MAGNESIUM PHOSPHATE, DIBASIC TRIH
SUBSTANCE NAME: CALCIUM FLUORIDE; TRIBASIC CALCIUM PHOSPHATE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; MAGNESIUM PHOSPHATE, DIBASIC TRIH
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: TABLET, SOLUBLE
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1940-01-01
END MARKETING DATE: 0000-00-00


Bioplasma HUMAN OTC DRUG Details:

Item DescriptionBioplasma from Hyland’s
LABELER NAME: Hyland’s
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 3; 3; 3; 3; 3; 3; 3; 6; 3; 3; 6([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1)
START MARKETING DATE: 1940-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54973-1068_f374654f-dda7-4e1d-99b7-5865175561c8
PRODUCT NDC: 54973-1068
APPLICATION NUMBER:

Other CALCIUM FLUORIDE; TRIBASIC CALCIUM PHOSPHATE; CALCIUM SULFATE ANHYDROUS; FERROSOFERRIC PHOSPHATE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM SULFATE; MAGNESIUM PHOSPHATE, DIBASIC TRIH Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hyland’sBioplasma
Newton Laboratories, Inc.Cell Salts
Rxhomeo Private Limited d.b.a. Rxhomeo, IncBio-Combination 28